MedTrace Logo

Bioactive Glass or Allogenic Bone in Pediatric Bone Cysts

NCT04737590 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-02-04

No results posted yet for this study

Summary

The Finnish Paediatric Orthopedic Study Group will perform a prospective, randomized, multicenter, clinical trial comparing two bone substitutes (allograft and bioactive glass, BonAlive®) in treating bone cysts in children (18 years or younger). The trial is carried out in five University Hospitals (Turku, Helsinki, Tampere, Oulu, Kuopio) in Finland.

Conditions

  • Bone Cysts

Interventions

DEVICE

Bioactive glass

Comparison of bioactive glass to allogenic bone in pediatric bone cysts

Sponsors & Collaborators

  • Bonalive Biomaterials Ltd

    collaborator INDUSTRY

  • Turku University Hospital

    lead OTHER_GOV

Principal Investigators

  • Ilkka Helenius, Prof · University of Helsinki

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-05
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04737590 on ClinicalTrials.gov